Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Olivia Felt-Baeyens"'
Autor:
Judith Marfurt, Florence Philippoz, Frédéric Lallemand, Philippe Perottet, Werner Kloeti, Kamel Besseghir, Olivia Felt-Baeyens, Robert Gurny
Publikováno v:
European Journal of Pharmaceutical Sciences, Vol. 26, No 1 (2005) pp. 124-129
UNIL088 is a water-soluble prodrug of cyclosporine A (CsA) developed for topical eye delivery. Such a prodrug has to fulfil two paradoxical requirements as it must be rapidly hydrolysed under physiological conditions but also retain a long shelf-life
Autor:
Frédéric Lallemand, Robert Gurny, Pascal Furrer, J-M Dumont, Olivia Felt-Baeyens, Kamel Besseghir, Marianne Gex-Fabry
Publikováno v:
International Journal of Pharmaceutics, Vol. 295, No 1-2 (2005) pp. 7-14
The purpose of this study is to demonstrate that a novel water-soluble prodrug of cyclosporine A (CsA) intended for topical ocular administration, does not induce eye irritation in a rabbit model and is able to generate therapeutic concentrations of
Autor:
Paolo Mora, Pascal Breton, Serge Sagodira, Olivia Felt-Baeyens, Simone Eperon, Yan Guex-Crosier, Robert Gurny
Publikováno v:
Current eye research, Vol. 30, No 5 (2005) pp. 355-361
PURPOSE: To assess ex vivo human scleral permeability to triamcinolone acetonide (TA). METHODS: The experiments were carried out using scleral samples and a Franz-type vertical diffusion cell. A suspension containing TA was prepared and placed in the
Autor:
Jérôme Berger, M. Reist, Olivia Felt-Baeyens, Robert Gurny, Abdellatif Chenite, Joachim M. Mayer
Publikováno v:
International Journal of Pharmaceutics, Vol. 288, No 2 (2005) pp. 197-206
Unisciences
Unisciences
To prepare transparent chitosan/beta-glycerophosphate (betaGP) pseudo-thermosetting hydrogels, the deacetylation degree (DD) of chitosan has been modified by reacetylation with acetic anhydride. Two methods (I and II) of reacetylation have been compa
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 56:307-318
Systemic administration of cyclosporine A (CsA) is commonly used in the treatment of local ophthalmic conditions involving cytokines, such as corneal graft rejection, autoimmune uveitis and dry eye syndrome. Local administration is expected to avoid
Autor:
Pascal Furrer, Olivia Felt-Baeyens, Robert Gurny, Khadija Schwach-Abdellaoui, Peter Westh, Birgit Lundskov Fuhlendorff, Fanny Guillaumie, Søren Nymand
Publikováno v:
Journal of Biomedical Materials Research Part A.
This work presents a comparative study of various hyaluronic acids (HA) produced by fermentation of either Bacillus subtilis or Streptococcus towards the selection of an optimal molecular weight (MW) HA for the preparation of topical ophthalmic formu
Autor:
Gérard Hopfgartner, Emmanuel Varesio, Robert Gurny, Frédéric Lallemand, Leila Bossy, Olivia Felt-Baeyens
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 67, No 2 (2007) pp. 555-61
UNIL088 is a water-soluble prodrug of cyclosporine A (CsA) designed for topical ocular delivery. The pro-moiety is grafted via an ester function to CsA and the solubilizing group is a phosphate ion. The aim of this study was to elucidate the conversi
Autor:
Robert Gurny, Olivia Felt-Baeyens
Publikováno v:
Drugs and the Pharmaceutical Sciences ISBN: 9780824708696
Modified-Release Drug Delivery Technology
Modified-Release Drug Delivery Technology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f266d10681476c223d5710d254cc4f52
https://doi.org/10.1201/9780203910337.ch28
https://doi.org/10.1201/9780203910337.ch28
Autor:
Olivia Felt-Baeyens, Robert Gurny
Publikováno v:
BMC News and views. 2
Autor:
Jérôme Berger, Abdellatif Chenite, Robert Gurny, M. Reist, Joachim M. Mayer, Olivia Felt-Baeyens
Publikováno v:
International Journal of Pharmaceutics. 296:162